본문으로 건너뛰기
← 뒤로

Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report.

Cancer reports (Hoboken, N.J.) 2026 Vol.9(4) p. e70546

Akazawa Y, Sato T, Yagami Y, Kesen Y, Furo T, Watanabe A, Endo J, Nakano M, Kurata H, Matsuo H, Nakahara Y, Sasaki J, Naoki K

📝 환자 설명용 한 줄

[BACKGROUND] Transformation to small cell carcinoma, squamous cell carcinoma, and rarely, pleomorphic carcinoma (PC) has been reported to be found in EGFR-mutated lung cancer with acquired resistance

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Akazawa Y, Sato T, et al. (2026). Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report.. Cancer reports (Hoboken, N.J.), 9(4), e70546. https://doi.org/10.1002/cnr2.70546
MLA Akazawa Y, et al.. "Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report.." Cancer reports (Hoboken, N.J.), vol. 9, no. 4, 2026, pp. e70546.
PMID 42002533
DOI 10.1002/cnr2.70546

Abstract

[BACKGROUND] Transformation to small cell carcinoma, squamous cell carcinoma, and rarely, pleomorphic carcinoma (PC) has been reported to be found in EGFR-mutated lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). However, evidence for underlying factors including genomic profiles associated with PC transformation has been lacking.

[CASE] We report a case of EGFR-mutated lung adenocarcinoma that transformed to PC confirmed by an autopsy after stereotactic radiotherapy and treatment with EGFR-TKIs. Comprehensive genomic profiling of the autopsy tissue revealed BRAF G466A, KRAS L19F, and NF1 Q2324* mutations in addition to EGFR E746_A750del. Anti-cancer treatments with radiation and EGFR-TKIs accompanying these gene alterations might induce the histological transformation and resistance to EGFR-TKIs.

[CONCLUSION] This report adds an insight into the involvement of genetic events in histological transformation in EGFR-mutated lung cancer.

MeSH Terms

Humans; ErbB Receptors; Adenocarcinoma of Lung; Mutation; Lung Neoplasms; Male; Protein Kinase Inhibitors; Cell Transformation, Neoplastic; Proto-Oncogene Proteins p21(ras); Aged; Adenocarcinoma; Middle Aged; Fatal Outcome; Drug Resistance, Neoplasm; Proto-Oncogene Proteins B-raf; Neurofibromin 1

같은 제1저자의 인용 많은 논문 (2)